WallStSmart
NDRA

ENDRA Life Sciences Inc

NASDAQ: NDRA · HEALTHCARE · DIAGNOSTICS & RESEARCH

$4.87
+0.41% today

Updated 2026-04-30

Market cap
$5.98M
P/E ratio
P/S ratio
1,838.78x
EPS (TTM)
$-8.93
Dividend yield
52W range
$3 – $12
Volume
0.1M

ENDRA Life Sciences Inc (NDRA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$559355.00$1.41M$515582.00$351622.00$6174.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)+152.1%-63.4%-31.8%-98.2%-100.0%
Cost of revenue$259145.00$666233.00$235878.00$172782.00$0.00$115011.00$165249.00$224415.00$234258.00$275451.00$206172.00
Gross profit$300210.00$743831.00$279704.00$178840.00$6174.00$-115011.00$-165249.00$-224415.00$-234258.00$-275451.00$-206172.00
Gross margin53.7%52.8%54.3%50.9%100.0%
R&D$873167.00$1.04M$495377.00$1.93M$4.72M$6.57M$5.92M$5.48M$6.55M$5.00M$3.19M$1.85M
SG&A$896926.00$1.22M$1.54M$2.75M$3.75M$3.86M$5.00M$4.94M$5.17M$4.70M$7.06M$3.72M
Operating income$-1.53M$-1.57M$-1.79M$-4.63M$-9.02M$-10.84M$-11.50M$-11.50M$-13.16M$-10.52M$-10.82M$-5.76M
Operating margin-272.8%-111.2%-347.5%-1315.6%-146080.5%
EBITDA$-1.49M$-1.50M$-1.73M$-4.56M$-9.02M$-10.84M$-11.33M$-11.01M$-12.94M$-9.78M$-10.77M$-5.61M
EBITDA margin-266.2%-106.1%-334.9%-1298.1%-146080.5%
EBIT$-1.53M$-1.57M$-1.79M$-4.63M$-9.09M$-10.95M$-11.49M$-11.23M$-13.18M$-10.06M$-10.82M$-5.76M
Interest expense$0.00$0.00$0.00$0.00$729241.00$2.36M$232426.00$267055.00$21533.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.18M$-2.28M$-2.78M$-5.38M$-9.80M$-13.31M$-11.73M$-11.23M$-13.18M$-10.06M$-11.51M$-7.03M
Net income growth (YoY)-4.5%-21.8%-93.7%-82.2%-35.8%+11.9%+4.2%-17.3%+23.7%-14.4%+38.9%
Profit margin-389.9%-161.6%-538.3%-1529.2%-158669.6%